The company's financial position appears increasingly strained as the debt-to-equity ratio surged to 0.90 in 2026Q1 from 0.29 in 2023Q4, while total equity eroded to $4.7M.
| Metric | TTM | Jan'26 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 24.58M | 25.25M | 23.56M | 27.45M | 35.77M | 42.25M | 25.36M | 30.55M | 39.62M | 39.45M | 45.87M | 30.77M | 32.89M | 31.97M | 27.05M | 29.51M | 26.37M | 26.33M | 25.69M | 35.5M | 37.87M | 38.92M | 32.65M | 33.47M | 31.05M | 30.33M | 31.53M | 29M | 25.9M | 24.5M | 17.8M |
| Cash & Short-Term Investments | 4.59M | 6.03M | 2.39M | 7.03M | 13.92M | 23.85M | 11.63M | 12.65M | 21.19M | 21.71M | 23.75M | 9.99M | 13.3M | 13.44M | 11.9M | 10.79M | 9.01M | 9.38M | 5.31M | 5.81M | 21.05M | 21.43M | 13.7M | 16.29M | 11.54M | 9.1M | 12.99M | 13.15M | 5.8M | 9.9M | 5M |
| Cash Only | 4.59M | 6.03M | 2.39M | 7.03M | 13.92M | 23.85M | 11.63M | 12.65M | 21.19M | 21.71M | 23.75M | 9.99M | 13.3M | 13.44M | 11.9M | 10.79M | 9.01M | 9.38M | 5.31M | 5.81M | 21.05M | 12.65M | 10.38M | 10.54M | 9.19M | 4.61M | 10M | 9.64M | 5.8M | 9.9M | 5M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.78M | 3.32M | 5.75M | 2.36M | 4.49M | 3M | 3.5M | 0 | 0 | 0 |
| Accounts Receivable | 8.42M | 9.54M | 8.39M | 9.65M | 9.77M | 9.72M | 7.29M | 9.32M | 9.08M | 7.86M | 10.03M | 9.28M | 8.34M | 7.34M | 5.48M | 5.55M | 7.53M | 7.48M | 8.2M | 8.88M | 6.05M | 6.59M | 7.4M | 6.55M | 8.04M | 8.07M | 8.01M | 8.16M | 7.6M | 6.1M | 5.4M |
| Days Sales Outstanding | 65.12 | 66.14 | 62.95 | 67.93 | 62.58 | 65.79 | 73.2 | 78.32 | 77.82 | 69 | 79.27 | 81.13 | 71.08 | 70.05 | 59.07 | 61.1 | 62.87 | 63.2 | 61.67 | 58.34 | 61.52 | 64.95 | 82.37 | 75.4 | 95.76 | 107.94 | 87.44 | 111.32 | 117.54 | 123.01 | 158.95 |
| Inventory | 9.32M | 7.88M | 10.82M | 9.91M | 10.61M | 7.61M | 5.71M | 8.17M | 8.79M | 9.38M | 11.64M | 11.11M | 9.12M | 10.61M | 8.04M | 6.66M | 9.21M | 9M | 11.64M | 15.97M | 9.5M | 8.59M | 8.92M | 8.72M | 10.72M | 12.56M | 9.72M | 7.26M | 6.5M | 4M | 1.9M |
| Days Inventory Outstanding | 89.49 | 86.16 | 135.37 | 120.27 | 122.51 | 89.44 | 100.32 | 116.96 | 127.73 | 131.24 | 167.85 | 185.91 | 155.47 | 196.63 | 167.46 | 144.08 | 147.53 | 143.19 | 147.32 | 186.51 | 202.77 | 166.37 | 181.71 | 180.57 | 229.65 | 322.78 | 258.14 | 241.4 | 247.14 | 202.78 | 147.55 |
| Other Current Assets | 2.25M | 1.8M | 1.96M | 856K | 1.47M | 0 | 0 | 0 | 547K | 500K | 450K | 386K | 1.63M | 0 | 510K | 6.04M | 6.55M | 0 | 0 | 3.8M | 0 | 1.42M | 1.81M | 972K | 0 | 0 | 805K | 437K | 6M | 4.5M | 5.5M |
| Total Non-Current Assets | 3.69M | 3.9M | 5.57M | 6.99M | 6.52M | 6.43M | 2.61M | 4.26M | 2.05M | 2.19M | 2.28M | 11.05M | 8.92M | 1.71M | 1.86M | 2.64M | 2.85M | 1.96M | 2.54M | 11.15M | 2.31M | 2.19M | 6.44M | 2.37M | 3.22M | 3.46M | 3.5M | 3.66M | 2.5M | 2.2M | 5.9M |
| Property, Plant & Equipment | 635K | 826K | 1.91M | 2.98M | 2.13M | 2.99M | 1.88M | 3.49M | 1.22M | 1.4M | 1.53M | 1.1M | 735K | 543K | 483K | 325K | 360K | 486K | 832K | 1.62M | 1.09M | 1.11M | 852K | 850K | 950K | 1.53M | 1.9M | 2.14M | 2.3M | 2.1M | 700K |
| Fixed Asset Turnover | 54.51x | 63.77x | 25.52x | 17.39x | 26.79x | 18.01x | 19.36x | 12.43x | 34.92x | 29.65x | 30.09x | 37.82x | 58.25x | 70.48x | 70.10x | 102.03x | 121.37x | 88.91x | 58.33x | 34.26x | 33.03x | 33.24x | 38.51x | 37.29x | 32.25x | 17.77x | 17.57x | 12.48x | 10.26x | 8.62x | 17.71x |
| Goodwill | 965K | 965K | 965K | 965K | 965K | 965K | 533K | 533K | 533K | 533K | 533K | 533K | 533K | 533K | 533K | 533K | 473K | 0 | 0 | 3.24M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 904K | 984K | 1.31M | 1.64M | 1.98M | 2.21M | 68K | 84K | 100K | 116K | 132K | 268K | 284K | 328K | 554K | 745K | 1.8M | 1.15M | 1.47M | 5.94M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100K | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9.97M | -10.06M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.32M | 0 | 0 | 1K | 4K | -3K | 0 | 0 | 0 |
| Other Non-Current Assets | 1.19M | 1.12M | 1.39M | 1.4M | 1.46M | 271K | 132K | 151K | 201K | 143K | 80K | 164K | 221K | 303K | 287K | 1.04M | 218K | 323K | 229K | 347K | 1.22M | 0 | 4.32M | 0 | 0 | 1.92M | 1.59M | 1.52M | 100K | 100K | 5.2M |
| Total Assets | 28.27M | 29.15M | 29.14M | 34.44M | 42.29M | 48.69M | 27.97M | 34.81M | 41.67M | 41.65M | 48.14M | 41.82M | 41.82M | 33.68M | 28.91M | 32.15M | 29.22M | 28.29M | 28.23M | 46.65M | 40.18M | 41.1M | 39.09M | 35.84M | 34.27M | 33.79M | 35.02M | 32.66M | 28.4M | 26.7M | 23.7M |
| Asset Turnover | 1.79x | 1.81x | 1.67x | 1.51x | 1.35x | 1.11x | 1.30x | 1.25x | 1.02x | 1.00x | 0.96x | 1.00x | 1.02x | 1.14x | 1.17x | 1.03x | 1.50x | 1.53x | 1.72x | 1.19x | 0.89x | 0.90x | 0.84x | 0.88x | 0.89x | 0.81x | 0.95x | 0.82x | 0.83x | 0.68x | 0.52x |
| Asset Growth % | -22.26% | 0.05% | -15.39% | -18.57% | -13.14% | 74.07% | -19.66% | -16.46% | 0.06% | -13.5% | 15.11% | 0.01% | 24.17% | 16.48% | -10.07% | 10.02% | 3.28% | 0.23% | -39.5% | 16.12% | -2.26% | 5.14% | 9.08% | 4.57% | 1.43% | -3.53% | 7.22% | 15.02% | 6.37% | 12.66% | 270.31% |
| Total Current Liabilities | 12.83M | 13.21M | 16.56M | 12.97M | 12.45M | 12.65M | 8.68M | 9.78M | 11.09M | 10.39M | 8.46M | 7.43M | 7.04M | 7.36M | 6.37M | 8.91M | 9.2M | 13.12M | 16.48M | 27.84M | 8.02M | 6.59M | 7.31M | 5M | 4.07M | 3.96M | 4.53M | 5.16M | 2.5M | 2.8M | 2.2M |
| Accounts Payable | 5.75M | 5.5M | 6.99M | 4.5M | 3.86M | 2.77M | 1.15M | 2.59M | 2.52M | 1.72M | 1.99M | 2.22M | 1.76M | 2.28M | 2.1M | 1.58M | 1.51M | 1.87M | 2.42M | 2.89M | 1.83M | 1.09M | 1.23M | 1.03M | 657K | 1.18M | 1.41M | 1.13M | 879K | 800K | 500K |
| Days Payables Outstanding | 57.57 | 60.18 | 87.41 | 54.62 | 44.56 | 32.56 | 20.16 | 37.09 | 36.55 | 24.12 | 28.75 | 37.21 | 29.97 | 42.24 | 43.87 | 34.19 | 24.25 | 29.79 | 30.55 | 33.72 | 39.06 | 21.18 | 25.11 | 21.31 | 14.07 | 30.22 | 37.39 | 37.53 | 33.42 | 40.56 | 38.83 |
| Short-Term Debt | 424K | 699K | 1.73M | 0 | 0 | 0 | 1.25M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.52M | 6M | 9.88M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 8.68M | 2.16M | 3.49M | 3.33M | 3.38M | 3.45M | 938K | 2.23M | 2.23M | 2.52M | 1.38M | 1.31M | 1.18M | 1.13M | 1M | 1.13M | 2.13M | 2.4M | 2.74M | 3.35M | 1.42M | 1.07M | 910K | 596K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.89M | 4.85M | 770K | 1.62M | 2.45M | 3.19M | 1.97M | 2.78M | 3.23M | 3.63M | 2.64M | 2.22M | 2.13M | 2.06M | 1.7M | 4.4M | 4.64M | 0 | 0 | 0 | 0 | 0 | 0 | -3.38M | 0 | 0 | 3.12M | 4.03M | 1.62M | 2M | 1.7M |
| Current Ratio | 1.92x | 1.91x | 1.42x | 2.12x | 2.87x | 3.34x | 2.92x | 3.12x | 3.57x | 3.80x | 5.42x | 4.14x | 4.67x | 4.34x | 4.25x | 3.31x | 2.87x | 2.01x | 1.56x | 1.28x | 4.72x | 5.91x | 4.47x | 6.69x | 7.62x | 7.67x | 6.97x | 5.62x | 10.36x | 8.75x | 8.09x |
| Quick Ratio | 1.19x | 1.32x | 0.77x | 1.35x | 2.02x | 2.74x | 2.26x | 2.29x | 2.78x | 2.89x | 4.04x | 2.65x | 3.38x | 2.90x | 2.99x | 2.56x | 1.87x | 1.32x | 0.85x | 0.70x | 3.54x | 4.60x | 3.25x | 4.94x | 4.99x | 4.49x | 4.82x | 4.21x | 7.76x | 7.32x | 7.23x |
| Cash Conversion Cycle | 97.03 | 92.12 | 110.91 | 133.58 | 140.54 | 122.67 | 153.36 | 158.2 | 169.01 | 176.12 | 218.37 | 229.84 | 196.57 | 224.44 | 182.67 | 171 | 186.15 | 176.6 | 178.43 | 211.12 | 225.23 | 210.14 | 238.96 | 234.67 | 311.34 | 400.51 | 308.19 | 315.2 | 331.26 | 285.23 | 267.68 |
| Total Non-Current Liabilities | 10.71M | 11.02M | 10.48M | 11.94M | 12.61M | 12.74M | 1.92M | 2.33M | 623K | 732K | 523K | 704K | 1.04M | 461K | 640K | 810K | 596K | 149K | 0 | 0 | 0 | 0 | 5.17M | 3.38M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 3.77M | 3.73M | 1M | 0 | 0 | 0 | 1.25M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 485K | 98K | 811K | 1.75M | 732K | 1.73M | 282K | 1.79M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 440K | 387K | 314K | 164K | 132K | 83K | 103K | 175K | 623K | 732K | 523K | 704K | 1.04M | 461K | 640K | 810K | 596K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 23.54M | 24.23M | 27.04M | 24.91M | 25.06M | 25.39M | 10.6M | 12.11M | 11.71M | 11.12M | 8.98M | 8.13M | 8.08M | 7.82M | 7.01M | 9.72M | 9.79M | 13.27M | 16.48M | 27.84M | 8.02M | 6.59M | 7.31M | 5M | 4.07M | 3.96M | 4.53M | 5.16M | 2.5M | 2.8M | 2.2M |
| Total Debt | 4.28M | 4.53M | 4.64M | 2.75M | 1.77M | 2.66M | 4.19M | 3.21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.52M | 6M | 9.88M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10K |
| Net Debt | -319K | -1.5M | 2.26M | -4.29M | -12.15M | -21.2M | -7.44M | -9.44M | -21.19M | -21.71M | -23.75M | -9.99M | -13.3M | -13.44M | -11.9M | -10.79M | -9.01M | -5.86M | 693K | 4.07M | -21.05M | -12.65M | -10.38M | -10.54M | -9.19M | -4.61M | -10M | -9.64M | -5.8M | -9.9M | -4.99M |
| Debt / Equity | 0.90x | 0.92x | 2.21x | 0.29x | 0.10x | 0.11x | 0.24x | 0.14x | - | - | - | - | - | - | - | - | - | 0.23x | 0.51x | 0.53x | - | - | - | - | - | - | - | - | - | - | 0.00x |
| Debt / EBITDA | -2.81x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.03x | - | - | - | - | - | - | - | - | - | - | - | - | 0.01x |
| Net Debt / EBITDA | 0.21x | - | - | - | - | - | - | - | - | - | - | -12.34x | -4.42x | -4.30x | - | -4.60x | -2.72x | -1.71x | - | - | - | -5.64x | - | -16.09x | -13.35x | - | -2.72x | -3.65x | -2.32x | -3.19x | -4.16x |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | 1.06x | 7.10x | -1.29x | 9.24x | 46.12x | 14.00x | -13.29x | -33.56x | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 4.73M | 4.92M | 2.1M | 9.52M | 17.23M | 23.3M | 17.37M | 22.7M | 29.96M | 30.52M | 39.16M | 33.69M | 33.74M | 25.85M | 21.91M | 22.43M | 19.43M | 15.03M | 11.75M | 18.81M | 32.16M | 34.52M | 31.78M | 30.83M | 30.2M | 29.83M | 30.5M | 27.5M | 25.9M | 23.9M | 21.5M |
| Equity Growth % | 711.27% | 134.72% | -77.98% | -44.74% | -26.04% | 34.16% | -23.51% | -24.22% | -1.84% | -22.06% | 16.24% | -0.14% | 30.49% | 18.03% | -2.32% | 15.44% | 29.29% | 27.92% | -37.55% | -41.51% | -6.84% | 8.6% | 3.08% | 2.11% | 1.22% | -2.19% | 10.89% | 6.19% | 8.37% | 11.16% | 357.45% |
| Book Value per Share | 0.27 | 0.29 | 0.13 | 0.59 | 1.08 | 1.51 | 1.25 | 1.66 | 2.46 | 2.64 | 3.85 | 3.33 | 3.26 | 2.56 | 2.45 | 2.19 | 1.92 | 1.68 | 1.33 | 2.27 | 4.17 | 4.38 | 4.41 | 4.16 | 4.36 | 4.42 | 4.19 | 4.02 | 3.83 | 3.54 | 3.44 |
| Total Shareholders' Equity | 4.73M | 4.92M | 2.1M | 9.52M | 17.23M | 23.3M | 17.37M | 22.7M | 29.96M | 30.52M | 39.16M | 33.69M | 33.74M | 25.85M | 21.91M | 22.43M | 19.43M | 15.03M | 11.75M | 18.81M | 32.16M | 34.52M | 31.78M | 30.83M | 30.2M | 29.83M | 30.5M | 27.5M | 25.9M | 23.9M | 21.5M |
| Common Stock | 174K | 174K | 174K | 172K | 169K | 168K | 148K | 147K | 145K | 126K | 124K | 111K | 108K | 104K | 94K | 92K | 89K | 89K | 89K | 89K | 79K | 76K | 74K | 70K | 70K | 69K | 67K | 66K | 70K | 0 | 0 |
| Retained Earnings | -92.97M | -92.45M | -88.01M | -79.04M | -69.72M | -62.17M | -56.94M | -50.62M | -41.8M | -28.99M | -16.12M | -4.41M | -4.88M | -14.92M | -17.15M | -18.59M | -21.2M | -24.25M | -26.83M | -19.46M | 2.81M | 8.56M | 6.89M | 7.29M | 6.92M | 6.77M | 7.73M | 5.32M | 4M | 2.3M | 200K |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.08M | -430K | -430K | -430K | -430K | -430K | -430K | -430K | -430K | -430K | -430K | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -10K | -14K | 51K | -52K | -24K | 45K | -19K | 80K | 70K | -11.05M | -10.34M | -9.7M | 0 | 0 | 0 | -35K | -205K | -212K | -192K | -88K | 0 | -27K | -35K | -1K | 3K | 3K | 10K | -2K | 20K | -900K | -700K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Liquidity and capital constraints
As reported in financial statements, IRIDEX's total equity has contracted from $9.5M in 2023Q4 to $4.7M in 2026Q1, reflecting a persistent erosion of shareholder value driven by cumulative net losses that continue to weigh heavily on the company's overall financial position and long-term stability.
The consistent decline in equity highlights the company's inability to generate retained earnings, effectively forcing a reliance on external financing or asset liquidation to fund operations. This trajectory suggests that the business model has yet to reach a critical mass where operational scale can offset the ongoing depletion of capital.
Based on recent SEC filings, IRIDEX maintains a cash position of $4.6M as of 2026Q1, which represents a significant reduction from the $7.0M held in 2023Q4, indicating a narrowing buffer against operational shocks and potential volatility in working capital requirements for the medical device manufacturer.
While the current ratio of 1.92 suggests a superficial level of liquidity, the absolute cash balance remains low relative to the company's historical burn rate. Investors should monitor whether this liquidity level is sufficient to sustain R&D and sales efforts without necessitating dilutive capital raises in the near term.
According to reported figures, IRIDEX's debt-to-equity ratio has surged to 0.90 in 2026Q1 from 0.29 in 2023Q4, demonstrating that the company is increasingly reliant on debt financing to bridge the gap between its operational cash outflows and its capital requirements in a challenging market environment.
The rising leverage profile, coupled with persistent operating losses, suggests that the company's debt capacity may be reaching a ceiling. This shift warrants further investigation into the terms of existing credit facilities and the potential for refinancing risks if the company fails to improve its cash flow generation.
As indicated by the company's balance sheet data, deferred revenue has declined from $13.4M in 2023Q4 to $8.5M in 2026Q1, which may suggest a softening in the pipeline of future service obligations and a potential headwind for near-term revenue recognition and growth prospects.
The contraction in deferred revenue is a concerning indicator for a company that relies on a recurring revenue model through service contracts and consumable pull-through. This trend implies that the underlying demand for the company's installed base may be weakening, potentially impacting future cash inflows.
Quick answers to the most common questions about buying IRIX stock.
As of 2025, IRIDEX Corporation (IRIX) had total assets of $29.2M including $25.3M in current assets.
IRIDEX Corporation (IRIX) carries total debt of $4.5M, offset by $6.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
IRIDEX Corporation (IRIX) has total shareholders' equity (book value) of $4.9M ($0.29 book value per share). Book value represents the net worth of the company belonging to common stock holders.
IRIDEX Corporation (IRIX) reported a current ratio of 1.91x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.